Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Len Neckers

Showing results (1-10 of 168) with videos related to

Pageof 17
Sort By:
Breast Disease|February 3, 2005
Heat shock protein 90 is a rational molecular target in breast cancerLen Neckers
Chemistry & Biology|August 2, 2003
Screening for inducers of kinase degradationLen Neckers
Journal of Biosciences|May 31, 2007
Heat shock protein 90: the cancer chaperoneLen Neckers
Current Medicinal Chemistry|April 8, 2003
Development of small molecule Hsp90 inhibitors: utilizing both forward and reverse chemical genomics for drug identificationLen Neckers
Trends in Molecular Medicine|April 3, 2002
Hsp90 inhibitors as novel cancer chemotherapeutic agentsLen Neckers
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Heat shock protein 90 inhibition by 17-allylamino-17- demethoxygeldanamycin: a novel therapeutic approach for treating hormone-refractory prostate cancerLen Neckers
Current Topics in Medicinal Chemistry|July 18, 2006
Using natural product inhibitors to validate Hsp90 as a molecular target in cancerLen Neckers
Oncotarget|January 12, 2022
Oxygen-independent, CDK4/CDK6-dependent degradation of hypoxia-inducible factor-1α takes cancers' breath awayLen Neckers
Molecular Cell|July 23, 2011
A network of its own: the unique interactome of the Hsp90 cochaperone, Sba1/p23Thomas Prince, Len Neckers
Journal of the National Cancer Institute|October 23, 2016
A USE1ful Biomarker and Molecular Target in Lung Cancer?Wanping Xu, Len Neckers
Pageof 17

Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
Breast Disease|February 3, 2005
Heat shock protein 90 is a rational molecular target in breast cancerLen Neckers
Chemistry & Biology|August 2, 2003
Screening for inducers of kinase degradationLen Neckers
Journal of Biosciences|May 31, 2007
Heat shock protein 90: the cancer chaperoneLen Neckers
Current Medicinal Chemistry|April 8, 2003
Development of small molecule Hsp90 inhibitors: utilizing both forward and reverse chemical genomics for drug identificationLen Neckers
Trends in Molecular Medicine|April 3, 2002
Hsp90 inhibitors as novel cancer chemotherapeutic agentsLen Neckers
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Heat shock protein 90 inhibition by 17-allylamino-17- demethoxygeldanamycin: a novel therapeutic approach for treating hormone-refractory prostate cancerLen Neckers
Current Topics in Medicinal Chemistry|July 18, 2006
Using natural product inhibitors to validate Hsp90 as a molecular target in cancerLen Neckers
Oncotarget|January 12, 2022
Oxygen-independent, CDK4/CDK6-dependent degradation of hypoxia-inducible factor-1α takes cancers' breath awayLen Neckers
Molecular Cell|July 23, 2011
A network of its own: the unique interactome of the Hsp90 cochaperone, Sba1/p23Thomas Prince, Len Neckers
Journal of the National Cancer Institute|October 23, 2016
A USE1ful Biomarker and Molecular Target in Lung Cancer?Wanping Xu, Len Neckers
Pageof 17